全文获取类型
收费全文 | 23190篇 |
免费 | 1840篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 390篇 |
儿科学 | 819篇 |
妇产科学 | 373篇 |
基础医学 | 2381篇 |
口腔科学 | 522篇 |
临床医学 | 2056篇 |
内科学 | 5096篇 |
皮肤病学 | 547篇 |
神经病学 | 1272篇 |
特种医学 | 1081篇 |
外国民族医学 | 1篇 |
外科学 | 4527篇 |
综合类 | 321篇 |
一般理论 | 15篇 |
预防医学 | 1107篇 |
眼科学 | 806篇 |
药学 | 2037篇 |
中国医学 | 37篇 |
肿瘤学 | 1716篇 |
出版年
2023年 | 197篇 |
2022年 | 182篇 |
2021年 | 842篇 |
2020年 | 475篇 |
2019年 | 814篇 |
2018年 | 938篇 |
2017年 | 616篇 |
2016年 | 636篇 |
2015年 | 672篇 |
2014年 | 1017篇 |
2013年 | 1184篇 |
2012年 | 1745篇 |
2011年 | 1722篇 |
2010年 | 872篇 |
2009年 | 817篇 |
2008年 | 1292篇 |
2007年 | 1219篇 |
2006年 | 1132篇 |
2005年 | 978篇 |
2004年 | 881篇 |
2003年 | 748篇 |
2002年 | 645篇 |
2001年 | 584篇 |
2000年 | 549篇 |
1999年 | 480篇 |
1998年 | 145篇 |
1997年 | 118篇 |
1996年 | 125篇 |
1995年 | 139篇 |
1994年 | 113篇 |
1993年 | 97篇 |
1992年 | 267篇 |
1991年 | 284篇 |
1990年 | 248篇 |
1989年 | 212篇 |
1988年 | 208篇 |
1987年 | 219篇 |
1986年 | 192篇 |
1985年 | 177篇 |
1984年 | 111篇 |
1983年 | 125篇 |
1982年 | 85篇 |
1981年 | 70篇 |
1979年 | 129篇 |
1978年 | 77篇 |
1977年 | 68篇 |
1975年 | 58篇 |
1974年 | 65篇 |
1973年 | 88篇 |
1970年 | 58篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
2.
3.
Cheryl L. Rock PhD RD Cynthia A. Thomson PhD RD Kristen R. Sullivan MS MPH Carol L. Howe MD MLS Lawrence H. Kushi ScD Bette J. Caan DrPH Marian L. Neuhouser PhD RD Elisa V. Bandera MD PhD Ying Wang PhD Kimberly Robien PhD RD Karen M. Basen-Engquist PhD MPH Justin C. Brown PhD Kerry S. Courneya PhD Tracy E. Crane PhD RDN David O. Garcia PhD FACSM Barbara L. Grant MS RDN CSO FAND Kathryn K. Hamilton MA RDN CSO CDN FAND Sheri J. Hartman PhD Stacey A. Kenfield ScD Maria Elena Martinez PhD Jeffrey A. Meyerhardt MD MPH Larissa Nekhlyudov MD MPH Linda Overholser MD Alpa V. Patel PhD Bernardine M. Pinto PhD Mary E. Platek PhD RD CDN Erika Rees-Punia PhD MPH Colleen K. Spees PhD MEd RD LD FAND Susan M. Gapstur PhD Marjorie L. McCullough ScD RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis. 相似文献
4.
A. D. Kane J. Soar R. A. Armstrong E. Kursumovic M. T. Davies F. C. Oglesby L. Cortes C. Taylor I. K. Moppett S. Agarwal J. Cordingley J. Dorey S. J. Finney G. Kunst D. N. Lucas G. Nickols R. Mouton J. P. Nolan B. Patel V. J. Pappachan F. Plaat B. R. Scholefield J. H. Smith L. Varney T. M. Cook collaborators 《Anaesthesia》2023,78(6):701-711
Detailed contemporary knowledge of the characteristics of the surgical population, national anaesthetic workload, anaesthetic techniques and behaviours are essential to monitor productivity, inform policy and direct research themes. Every 3–4 years, the Royal College of Anaesthetists, as part of its National Audit Projects (NAP), performs a snapshot activity survey in all UK hospitals delivering anaesthesia, collecting patient-level encounter data from all cases under the care of an anaesthetist. During November 2021, as part of NAP7, anaesthetists recorded details of all cases undertaken over 4 days at their site through an online survey capturing anonymous patient characteristics and anaesthetic details. Of 416 hospital sites invited to participate, 352 (85%) completed the activity survey. From these, 24,177 reports were returned, of which 24,172 (99%) were included in the final dataset. The work patterns by day of the week, time of day and surgical specialty were similar to previous NAP activity surveys. However, in non-obstetric patients, between NAP5 (2013) and NAP7 (2021) activity surveys, the estimated median age of patients increased by 2.3 years from median (IQR) of 50.5 (28.4–69.1) to 52.8 (32.1–69.2) years. The median (IQR) BMI increased from 24.9 (21.5–29.5) to 26.7 (22.3–31.7) kg.m–2. The proportion of patients who scored as ASA physical status 1 decreased from 37% in NAP5 to 24% in NAP7. The use of total intravenous anaesthesia increased from 8% of general anaesthesia cases to 26% between NAP5 and NAP7. Some changes may reflect the impact of the COVID-19 pandemic on the anaesthetic population, though patients with confirmed COVID-19 accounted for only 149 (1%) cases. These data show a rising burden of age, obesity and comorbidity in patients requiring anaesthesia care, likely to impact UK peri-operative services significantly. 相似文献
5.
Alexander D. Sherry MD Kelsey L. Corrigan MD MPH Ramez Kouzy MD Joseph Abi Jaoude MD Yumeng Yang MS Roshal R. Patel MD Douglas J. Totten MD MBA Neil B. Newman MD MS Prajnan Das MD MS MPH Cullen Taniguchi MD PhD Bruce Minsky MD Rebecca A. Snyder MD MPH C. David Fuller MD PhD Ethan Ludmir MD 《Cancer》2023,129(21):3430-3438
6.
7.
8.
Mehran Afshar Hiten R. H. Patel Ankit Jain Abhishek Kumar Prashant Patel Nicholas D. James 《Expert review of anticancer therapy》2019,19(6):529-532
Background: Patients with metastatic renal cell carcinoma (mRCC) are commonly treated with tyrosine kinase inhibitors (TKIs). An adverse effect frequently suffered by patients is lethargy, which often leads to dose reduction or drug cessation. We aimed to assess whether hypogonadism is related to treatment with TKIs.Methods: We prospectively assessed gonadal function in 41 consecutive males with mRCC treated with TKIs. Demographic, clinical, and biochemical variables were collected, and statistical analyses performed to assess correlation and survival. Data Capture for each patient was perfomred at the time of entry in the study.Results: There was a 77% incidence of hypogonadism in this cohort. Assessment of testosterone level and time on TKI treatment revealed a correlation with linear regression R2 of 0.24 and regression coefficient of ?0.003 (p = 0.019). Odds ratio for hypogonadism at >30 months on TKIs was 12.1 (p = 0.011). Odds ratios above and below this value showed a confirmatory trend, suggesting that this may be a chronic adverse effect.Conclusions: Our findings provide an important and robust hypothesis for a prospective clinical trial to be performed.Expert Opinion: Given the present data, patients who have symptoms suggestive of hypogonadism must have an assessment of gonadal function and be treated. 相似文献
9.
Sandberg David I. Yu Bangning Patel Rajan Hagan John Miesner Emilie Sabin Jennifer Smith Sarah Fletcher Stephen Shah Manish N. Sirianni Rachael W. Taylor Michael D. 《Journal of neuro-oncology》2019,141(2):449-457
Journal of Neuro-Oncology - DNA methylation inhibitors are logical therapeutic candidates for ependymomas originating in the posterior fossa of the brain. Our objective was to test the safety of... 相似文献
10.
Benjamin Rahmani Shrey Patel Omar Seyam Jason Gandhi Inefta Reid Noel Smith Sardar Ali Khan 《Hematological oncology》2019,37(5):537-547
Tumor lysis syndrome (TLS) is an oncologic emergency from the intracellular release of material in lysing malignant cells. The earlier it is treated, the less likely it is to be harmful to an individual and spread through the body. Common complications of TLS include arrhythmias, which are caused by hypocalcemia or hyperkalemia, renal failures due to hyperuricemia or hyperphosphatemia, and seizures. Furthermore, the risk to develop TLS varies widely based on several factors including factors that are related to disease, the patient, and the treatment of the patient. Laboratory data can be used to gauge the severity of TLS based on patient serum levels for specific markers. On the contrary, evidence of TLS via radiological imaging and electrocardiogram findings has been a limited way to evaluate TLS, indicating the need for further research in this area. Common trends of treatment have also been seen in the past several years, evident by case studies seen in the following literature review. 相似文献